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Summary  
Hypertension is a well-established risk factor for adverse cardiovascular events and older 
age is a risk factor for the development of hypertension.  Genome wide association studies 
have linked ATP2B1, the gene for the plasma membrane calcium ATPase 1 (PMCA1), to 
blood pressure (BP) and hypertension. Here we present the effects of reduction in the 
expression of PMCA1 on BP and small artery structure and function when combined with 
advancing age.   
Heterozygous PMCA1 null mice (PMCA1
Ht
) were generated and conscious BP was measured 
at 6 to 18 months of age. Passive and active properties of isolated small mesenteric arteries 
were examined by pressure myography.     
PMCA1
Ht 
mice exhibited normal BP at 6 and 9 months of age but developed significantly elevated BP 
when compared to age matched wild type controls at ≥ 12 months of age.  Decreased lumen 
diameter, increased wall thickness and increased wall:lumen ratio was observed in small mesenteric 
arteries from animals 9 months of age and older, indicative of eutrophic remodeling. Increases in 
mesenteric artery intrinsic tone and global intracellular calcium were evident in animals at both 6 
and 18 months of age. 
Thus, decreased expression of PMCA1 is associated with increased BP when combined with 
advancing age. Changes in arterial structure precede the elevation of BP. Pathways involving PMCA1 
may be a novel target for BP regulation in the elderly.   
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ABBREVIATIONS 
BP, blood pressure. CSA, cross sectional area (of arterial wall). NA, noradrenaline. NCX, 
sodium-calcium exchanger. PMCA, plasma membrane calcium ATPase. VSM, vascular 
smooth muscle. VSMC, vascular smooth muscle cell. W:L, arterial wall thickness to lumen 
diameter ratio. 
Introduction 
Cardiovascular diseases are the world’s leading cause of morbidity and mortality. 
Hypertension is a major modifiable risk factor for adverse cardiovascular events including 
stroke and aneurysm, and for heart and renal failure (Kearney et al. 2005). It is thought that 
at least 1 in 5 people worldwide have elevated blood pressure (BP) and that high BP 
contributes to around 9 million deaths worldwide annually (Mancia et al. 2013; Mozaffarian 
et al. 2016).  
Around 90% of people with hypertension suffer from essential, also known as primary, 
hypertension (Mancia et al. 2013), for which there is no single or clearly identifiable cause. 
The prevalence of essential hypertension increases with age, in a roughly linear relationship 
(Buford 2016), with around 60% of people over 70 years of age being hypertensive (Buford 
2016). With an aging global population it is projected that, by 2025, around 1.56 billion 
people will be hypertensive (Kearney et al. 2005). Thus, it is now ever more important to 
understand the underlying basis of BP control and the factors which may increase the risk of 
developing hypertension with aging.  
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Genome wide association studies (GWAS) have shown ATP2B1, the gene for plasma 
membrane calcium ATPase 1 (PMCA1), to be highly associated with BP and with essential 
hypertension, and importantly, demonstrated this as a consistent observation in different 
ethnic populations (Cho et al. 2009; Levy et al. 2009; Tabara et al. 2010). PMCA1 is a 
member of the P-type family of membrane ATPases, which actively extrude Ca
2+
 ions from 
cells. Of the 4 members of this family (4 separate genes) PMCA1 and PMCA4 are expressed 
in virtually all tissues and cell types in the body (Strehler et al. 2007; Cartwright et al. 2011), 
including the vasculature (Szewczyk et al. 2007; Kobayashi et al. 2012). A direct association 
between PMCA1 and BP has been demonstrated in animal studies where a reduction in the 
expression of PMCA1 has been shown to elevate BP (Kobayashi et al. 2012; Shin et al. 2013). 
However, the effect of PMCA1 on BP with advancing age is unknown.  
Vascular resistance is determined primarily by small pre-capillary arteries, less than 300µm 
internal diameter (in humans) (Mulvany & Aalkjaer 1990; Heagerty et al. 2010). It is well 
established that increased total peripheral resistance is the principal contributor to 
maintaining elevated BP (Heagerty et al. 2010). Enhanced vascular contractility is evident in 
mice with reduced arterial expression of PMCA1 (Shin et al. 2013). Whilst this indicates that 
PMCA1 may play some role in increased vascular resistance, there is a wealth of evidence to 
support the importance of structural changes of resistance arteries in hypertension (Rizzoni 
et al. 2003; Heagerty et al. 2010). Rearrangement of vascular smooth muscle cells (VSMCs) 
around a smaller lumen diameter without any global change in the arterial wall cross 
sectional area, termed eutrophic inward remodeling, has been shown to be a conventional 
small artery structural abnormality in patients with chronic essential hypertension (Mulvany 
& Aalkjaer 1990; Rizzoni et al. 2003; Heagerty et al. 2010; Little et al. 2016). Such changes in 
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small artery structure have strong prognostic significance in hypertensive patients, over and 
above all other known cardiovascular risk factors (Rizzoni et al. 2003; Mathiassen et al. 
2007b). Anti-hypertensive therapies which reduce both BP and reverse remodeling of 
resistance arteries have been shown to significantly reduce cardiovascular risk compared to 
interventions which reduce BP without affecting arterial structure (Buus et al. 2013). It 
remains an important topic of debate whether the remodeling is a consequence of 
hypertension or whether it precedes its development (Bakker et al. 2002; Martinez-Lemus 
et al. 2004; Izzard et al. 2006). Hence it is important to understand the mechanisms which 
underpin eutrophic inward remodeling, and the relationship between elevated BP and this 
remodeling. 
Therefore, we sought to determine how PMCA1 may be involved in arterial structure and 
function with aging. We herein present that global heterozygous deletion of PMCA1 in mice 
is associated with an age dependent elevation of BP with development of inward eutrophic 
remodeling, and that structural changes in mesenteric resistance arteries occur before a 
detectable increase in BP. 
Results 
PMCA1
Ht
 and PMCA1
flox/flox
 controls (WT) were born in the predicted ratio given that PMCA1 
total knockouts are embryonic lethal (Okunade et al. 2004), with neither male nor female 
PMCA1
Ht
 mice displaying reduced fertility compared to WT. PMCA1
Ht
 mice were 
indistinguishable by eye from WT, appeared healthy and appropriately active, and had 
similar lifespan to WT animals.  
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Immunoblot analysis of tissues from 6 month old animals showed that PMCA1 protein 
expression was reduced by 45-55% in the aorta, heart, brain and kidney of PMCA1
Ht
 mice 
compared to WT controls (Figure 1A.). The mRNA level of Atp2b1 was significantly reduced 
in the aorta of 6 month old PMCA1
Ht 
mice and also in aorta of 18 month old PMCA1
Ht 
mice 
compared to aged matched WT animals (Figure 1B). Reduced expression of PMCA1 had no 
significant effect on the mRNA level of Atp2b4 (gene for PMCA4 protein) in aorta from 6 
month (P=0.672) or 18 month old (P=0.503) animals, though the relative Atp2b4 mRNA level 
was found to be significantly reduced with age (Figure 1C). PMCA1 was detected throughout 
the aorta by immunohistochemical staining, with staining being of a lower intensity in the 
aorta of PMCA1
Ht
 mice compared to those from age matched WT animals (Figure 1D). The 
mRNA level of Atp2b1 was significantly reduced in lung endothelial cells of 6 month old 
PMCA1
Ht 
mice compared to aged matched WT animals (Figure 1E).  Reduced expression of 
PMCA1 had no significant effect on the mRNA level of other genes involved in Ca
2+
 
homeostasis including Atp2b4 (P=0.959), NCX1 (P=0.161) and TRPV5 (P=0.731) in kidney 
from 18 month old animals (Figure 1F, 1G & 1H respectively, T-test with Welch’s correction). 
Conscious peripheral systolic and diastolic BP of 6 and 9 month old PMCA1
Ht 
mice was not 
significantly different to that of age matched WT mice, however, PMCA1
Ht 
mice aged 12 
months and older had significantly elevated peripheral BP when compared to age matched 
WT animals (Figure 2A). No significant differences in pulse rate were found between 6 
month old and 18 month old PMCA1
Ht 
and WT animals (Figure 2B). Central BP of 6 month 
old animals, measured under anaesthesia, did not significantly differ between WT and 
PMCA1
Ht
 mice (Figure 2C). At 18 months of age no significant changes in cardiac function of 
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PMCA1
Ht 
mice, and no significant difference in heart size or cardiomyocyte cell area were 
found compared to age match WT mice (supplementary figure 1). 
As structural remodeling of resistance arteries is of key prognostic importance in essential 
hypertension (Rizzoni et al. 2003) we assessed the passive properties of isolated mesenteric 
arteries. Arteries from 6 month old PMCA1
Ht
 mice showed no significant difference in lumen 
diameter, wall thickness or cross sectional area (CSA) (figure 3A, D and J respectively) 
compared to age matched WT mice which also exhibited a similar level of BP. However, the 
calculated wall to lumen ratio (W:L) was significantly greater in PMCA1
Ht
 mice compared to 
WT at this age (Figure 3G). Importantly, arteries from 9 month old PMCA1
Ht
 mice, also 
‘normotensive’, displayed significantly reduced lumen diameter and significantly increased 
wall thickness and W:L (Figure 3B, E and H respectively) compared to arteries from age-
matched WT mice. CSA was not significantly different between genotypes at this age (one 
line adequately fits both datasets) (Figure 3K). Further, arteries from PMCA1
Ht 
animals with 
elevated BP (18 months) exhibited a significantly reduced lumen diameter (Figure 3C) and 
significantly increased wall thickness and W:L (Figure 3F & 3I respectively) with no 
significant change in CSA (one line adequately fits both datasets. Figure 3L).  
The distensibility of mesenteric arteries decreased with age, evidenced by a leftward shift in 
the stress-strain relationship from 18 month old mice relative to arteries from 6 month old 
mice, but was not modified by reduction in PMCA1 expression (Figure 4A). The incremental 
elastic modulus (β) of arteries from PMCA1
Ht 
and age-matched WT mice was not 
significantly different at each age (Figure 4B); however, compared to arteries from 6 month 
old mice, arteries from 18 month old mice displayed a significantly increased β value, 
indicative of reduced arterial distensibility (Figure 4B). 
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Whilst arterial structure clearly has an important influence on BP regulation we also sought 
to determine whether PMCA1 may mediate functional changes in resistance arteries. The 
magnitude of arterial contraction in response to 100mM K
+
 was not significantly different 
between PMCA1
Ht
 and WT mice in arteries from either 6 month (Figure 5A) or 18 month old 
(Figure 5B) mice. The cumulative dose-response profile to NA was very similar for arteries 
from both 6 month (LogEC50 WT: -5.606 ± 0.140, Ht: -5.806 ± 0.138, Figure 5C) and 18 month 
old aged (LogEC50 WT: -6.017 ± 0.242, Ht: -6.038 ± 0.115,
 
Figure 5D) PMCA1
Ht
 and WT mice. 
Subsequent to contraction induced with a single maximal dose of NA (30mM), simultaneous 
superfusion with the vasodilator acetylcholine (ACh) induced no significant difference in the 
maximal magnitude of relaxation for vessels from aged PMCA1
Ht 
and WT mice (32.03 ± 
10.45% and 39.68 ± 14.54% respectively, P=0.699. n= 4 & 5, T-test). Arteries from both WT 
and PMCA1
Ht 
mice were found to develop tone in Ca
2+
 containing conditions as seen by a 
significant divergence in the pressure-diameter relationship compared to the nominally Ca
2+
 
free condition (Supplementary figure 2). Calculated basal tone was found to be significantly 
increased in arteries from 6 month old (Figure 5E) and 18 month old (Figure 5F) PMCA1
Ht
 
mice. The basal F400/F500 emission ratio , indicative of  arterial [Ca
2+
]i (Austin & Wray 1995), 
was found to be significantly increased in arteries from PMCA1
Ht
 mice compared age-
matched WT animals at both 6 (Figure 5G) and 18 months (Figure 5H) of age. 
Discussion 
This study shows that reduced expression of PMCA1 in mice correlates to elevated BP and 
small artery remodeling when combined with aging. Importantly, we show that arterial 
remodeling precedes the development of elevated BP. Thus we propose that reduced 
expression of PMCA1 pre-disposes to the development of elevated BP when combined with 
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aging, suggesting that a PMCA1-mediated mechanism could be targeted to reduce the 
burden of high BP in older age.  
PMCA1 has been described as having a highly important housekeeping function as 
evidenced by embryonic lethality of global homozygous knockout mice (Okunade et al. 
2004). GWAS studies showing ATP2B1 to be highly associated with BP (Cho et al. 2009; Levy 
et al. 2009; Tabara et al. 2010) have highlighted the potential clinical relevance of ATP2B1. 
The importance of PMCA1 in BP regulation has been demonstrated in previous studies using 
tissue-specific ablation and silencing of Atp2b1 (Kobayashi et al. 2012; Shin et al. 2013). Our 
study shows that although reductions in global PMCA1 expression are not associated with 
significant alteration in BP of 6 month old mice, with advancing age increased BP is revealed.  
Aging has been shown to be a key contributor to cardiovascular disease risk (Buford 2016). 
Less than 10% of people under 30 years of age have essential hypertension; however, it is 
estimated that around 60% of people aged over 70 have elevated BP (Buford 2016). It is 
clear that both natural aging and genetic factors increase the risk for the development of 
hypertension and that risk factors may combine to enhance the prospect of adverse 
cardiovascular events or outcome (Buford 2016). The results of this study suggest that 
Atp2b1 may be an important risk factor for the development and progression of 
hypertension. As even relatively small (5mmHg) increases in BP are associated with 
increased risk of adverse cardiovascular events and mortality (Lewington et al. 2002; Tabara 
et al. 2012) managing risk factors for hypertension can have a large positive effect on a 
population’s health. 
This study utilised conscious BP measurement to assess the role of PMCA1. This method has 
the advantage of enabling repeated measures to be undertaken so a longitudinal study can 
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be conducted. It has previously been shown that volume-pressure recording (Coda 6 
system) of systolic BP closely agrees with measurements recorded simultaneously by radio 
telemetry (Feng et al. 2008). Elevated BP has previously been reported in mice with reduced 
PMCA1 expression at 3 months of age, but BP at other ages was not investigated (Fujiwara 
et al. 2014). The basis of our study was to directly generate mice globally heterozygous for 
PMCA1 and we have utilised Cre-recombinase under the CMV promoter. Fujiwara and 
colleagues have produced mice globally heterozygous for PMCA1 using a Cre-loxP and 
flippase recombination enzyme-flippase recognition target recombination system under the 
Tie2 promoter (Fujiwara et al. 2014), hence reduced expression of PMCA1 was engineered 
differently to our PMCA1
Ht
 mice. Whilst they do not quantify protein levels, Fujiwara and 
colleagues report approximately 70% reduction in Atp2b1 mRNA in brain, heart and aorta 
(Fujiwara et al. 2014), whereas our PMCA1
Ht
 mice display approximately a 50% reduction in 
gene and protein expression of PMCA1 from the aorta compared to WT animals. Therefore, 
a potentially greater degree of reduced PMCA1 expression may explain Fujiwara and 
colleagues observed BP phenotype in 3 month old mice designated heterozygous for 
Atp2b1; akin to complete ablation in VSMCs (Kobayashi et al. 2012). In contrast we report 
no significant difference in peripheral, and also central, BP between WT and PMCA1
Ht
 mice 
at 6 months of age. Therefore, despite both models being termed global heterozygotes any 
direct comparison should be made with caution.  
Complete genetic ablation of Atp2b1 specifically in VSMCs has been reported to be 
associated with reduced Ncx1 expression and with a significant increase in Atp2b4 
expression (Kobayashi et al. 2012). However, in the present study we report no significant 
change in the expression of Atp2b4 in aorta of PMCA1
Ht
 mice or in gene expression of renal 
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Ca
2+
 pumps and channels Atp2b4, Ncx1 or Trpv5 which are involved in transcellular 
reabsorption of Ca
2+
. The expression of other PMCA family members, isoforms 2 and 3, has 
been shown to be limited to specific tissues (Strehler et al. 2007), and we have no 
knowledge of these gene products being detected in the vascular system. Therefore, we 
suggest the effects we observed on BP and arterial remodeling in our PMCA1
Ht 
mice are 
unlikely to be strongly due to the expression of NCX1 or related PMCA family members.  
Inward eutrophic remodeling of resistance arteries, the rearrangement of existing wall 
material round a smaller lumen (Heagerty et al. 2010), is a key feature of essential 
hypertension and has been shown to be prognostic for elevated BP and associated with 
increased adverse cardiovascular risk (Rizzoni et al. 2003; Mathiassen et al. 2007b). Here we 
show significantly reduced lumen diameter, significantly increased wall thickness and no 
significant change in arterial wall cross sectional area from aged PMCA1
Ht
 mice, indicative of 
inward eutrophic remodeling. Importantly, inward eutrophic remodeling has been described 
as a feature of accelerated aging (Harvey et al. 2015). Strategies to at least slow the 
progression of vascular remodeling have clinical benefit in reducing BP and reducing the risk 
of adverse cardiovascular events in older people (Mathiassen et al. 2007a; Mulvany 2012; 
Harvey et al. 2015).  
Traditionally arterial structural changes were thought to be adaptive responses to elevated 
BP (Folkow 1982); however, others have demonstrated, in genetically modified animals, that 
vascular remodeling may precede an increase in BP (Zacchigna et al. 2006). Whilst there are 
clearly numerous factors which may influence the relationship between BP and the 
vasculature there is continuing debate concerning remodeling as a cause or effect of BP 
changes (Izzard et al. 2006). Our observations from PMCA1
Ht 
mice show evidence for inward 
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eutrophic remodeling in mesenteric resistance arteries before a detectable increase in BP. 
At 9 months of age significant changes in lumen diameter, wall thickness and W:L ratio were 
evident but with no significant increase in conscious peripheral BP. Although we observed 
no significant changes in lumen diameter or wall thickness in arteries from 6 month old 
PMCA1
Ht
 mice we did observe a significant increase in the W:L ratio, which does point to 
vascular changes occurring. This suggests that the remodeling, at least in part, is a relatively 
early feature of essential hypertension and is not a direct consequence of a prolonged and 
significant rise in BP in PMCA1
Ht
 mice. Reductions in arterial distensibility have been 
reported during normal physiological aging (Mitchell et al. 2004) and were demonstrated in 
the present study. However, this effect was not augmented by reduction in PMCA1 
expression. This observation correlates with the proposal that eutrophic remodeling can 
occur independently of vascular stiffening (Intengan & Schiffrin 2001). Therefore, we 
propose that elevated BP in aged PMCA1
Ht
 mice is not directly due to increased vascular 
stiffness but rather a direct PMCA1-associated mechanism of eutrophic remodeling.  
There is now a body of evidence to show that chronic vasoconstriction can induce eutrophic 
remodeling (Bakker et al. 2002; Eftekhari et al. 2007).  In the present study we show that, 
although contractile responses to high K
+ 
solution or to NA are similar in arteries from 
control and PMCA1
Ht 
mice at both 6 and 18 months of age, basal intrinsic tone is 
significantly increased in arteries from PMCA1
Ht
 mice. Furthermore, this enhanced tone is 
evident at 6 months of age suggesting it precedes the development of high BP. This   
supports previous reports showing that the basal tone of rat mesenteric arteries is 
enhanced during the development of hypertension (Izzard et al. 1996).  However, there 
remains debate about how vascular tone may contribute to BP regulation during the 
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established phase of hypertension. Spontaneously hypertensive rats (SHR) with chronically 
elevated BP (20 weeks old) have been shown to display no significant increase in mesenteric 
arterial tone compared to age matched ‘normotensive’ animals (Izzard et al. 1996), whereas 
basal tone was increased in middle cerebral arteries from 24 week old (established 
hypertension) but not 4 week old (pre-hypertensive) SHR (Gonzalez et al. 2008). These 
contrasting observations may reflect vascular bed differences or the calibre of artery 
studied. Previous studies have shown that silencing Atp2b1 increases myogenic tone (Shin 
et al. 2013) and here we show that reductions in the expression of PMCA1 are associated 
with enhanced basal tone. The observation of elevated tone in arteries from young and 
aged PMCA1
Ht
 mice, compared to age matched WT animals, is consistent with the notion 
that PMCA1 may contribute to the development and maintenance of hypertension. Herein 
we show a small reduction in the magnitude of basal tone with age, an effect which has 
been previously noted in mesenteric arteries and in arterioles isolated from the 
gastrocnemius and soleus muscles of rats (Kang et al. 2009; Vessieres et al. 2016). Such an 
age-related change has not been associated with an elevation of BP in rats (Kang et al. 
2009), comparable to aging WT mice used in this study. Of note we did not detect a 
significant effect of age on Atp2b1 mRNA levels in the aorta. As such, we propose that 
reduced PMCA1 expression not age per se contributes to relative enhanced arterial tone.  
Previous studies have shown that PMCA1 can regulate total [Ca
2+
]i in vascular smooth 
muscle (Kobayashi et al. 2012). In support of this we show here that resistance arteries from 
PMCA1
Ht
 mice pressurised to 60mmHg exhibit a significant elevation of the indo- 1 F400/F500 
emission ration, indicative of [Ca
2+
]i. This is consistent with the notion that in PMCA1
Ht 
mice, 
PMCA1 is modulating basal tone via effects on Ca
2+ 
homeostasis.  At present, the molecular 
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pathways underlying remodeling of resistance arteries remain unclear. Further assessment 
of how Ca
2+
-dependent pathways may contribute to the development and maintenance of 
high BP would be useful in designing future targeted treatment strategies for hypertension. 
In summary, we show that PMCA1
Ht 
mice develop increased BP with advancing age. In this 
animal model age dependent increases in BP are preceded by inward eutrophic remodeling 
of resistance arteries, and elevations in arterial basal [Ca
2+
]i and intrinsic tone. Although we 
cannot completely exclude the fact that changes in the expression of PMCA1 in other 
resistance arteries or non-vascular tissues may influence BP, an area for further 
investigation, we propose that effects of PMCA1 on the resistance vasculature play an 
important role in the development of hypertension with aging. The results of our study 
show that changes in the expression of PMCA1, which in younger mice does not significantly 
influence BP, does so when combined with aging, which is a well established risk factor for 
hypertension and cardiovascular disease (Buford 2016). The combination of all loci highly 
significantly associated with BP in GWAS has been reported to account for only up to 10% of 
the total estimated genetic component for BP (Tabara et al. 2012). Therefore, we propose 
that some of the ‘missing heritability’ for BP can be derived from an interaction between a 
genetic factor and aging. Changes in the expression and/or activity of PMCA1 may pre-
dispose to the development of hypertension. Therefore PMCA1-mediated mechanisms can 
be a target for potentially regulating abnormal BP with age, particularly relevant as the 
percentage of older people in the population is increasing.  
Experimental Procedures 
PMCA1
Ht 
mice 
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Loss of PMCA1 was engineered using a Cre-LoxP system, targeting sites flanking exon 2 in 
Atp2b1 containing the ATG transcription site. The targeting vector and mice were 
commercially generated by GenOway (Lyon, France). The targeting vector with two loxP 
sites flanking exon 2 of Atp2b1 was transfected into 129Sv/Pas ES cells. Fully validated ES 
cells clones were injected into C57Bl/6J blastocysts and the resulting male chimaeras were 
bred to generate homozygous PMCA1 flox mice (PMCA1
f/f
). To generate a constitutive 
deletion of PMCA1, PMCA1
f/f
 were mated with mice expressing Cre under the CMV 
promoter (CMV-Cre C57Bl/6J). Mice were maintained on a mixed genotype background and 
bred as brother/sister matings.  
All animals were maintained in a pathogen-free facility, housed under 12 hour light/dark 
cycle with ad libitum access to food and water. Studies were performed in accordance with 
the UK Home Office and institutional guidelines. All experiments in this study utilised male 
mice between 6 and 18 months of age. DNA was extracted from a sample of ear tissue for 
genotyping of each animal as described in supplementary materials. 
BP measurement 
Mice were regularly handled in our experimental facility following weaning. Conscious BP 
was measured by determining the tail blood volume with a volume-pressure sensor and an 
occlusion tail-cuff (Coda System, Kent Scientific) following a 3 day acclimatisation period for 
the animals. Restrained animals were placed on a warming platform set to 37°C. Blood flow 
to the distal tail was occluded with a maximal cuffing pressure of 250mmHg and then 
steadily deflated over 15 seconds for a single cycle. Systolic and diastolic pressures were 
automatically recorded during cuff deflation as blood flowed into the tail. 20 continuous 
cycles were performed, with accepted values (volume ≥15µL from calm and relaxed animals) 
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from the latter 10 cycles used for data analysis. 5 seconds between each cycle was 
programmed. Central BP was recorded, following intraperitoneal injection of Avertin 
(250mg/kg body weight), by insertion of a high-fidelity pressure volume catheter (Millar 
Instruments) into the right carotid artery. All BP experiments were performed between 
09:00-12:00 hours. 
Echocardiography 
Under isoflurane anaesthesia transthoracic two dimensional and M-mode echocardiography 
were performed using an Acuson Sequoia C256 system (Siemens) as previously described 
(Mohamed et al. 2016). 
Dissection of tissues 
Mice were killed by cervical dislocation. The entire mesenteric bed and thoracic aorta were 
removed and placed separately into ice cold HEPES buffer of composition (in mM) 127 NaCl, 
5.9 KCl, 1.2 MgSO4, 10 HEPES, 11.8 glucose, 2.4 CaCl2 at pH 7.4. Fat and adherent tissue was 
removed from the aorta and the tissue immersed in 4% paraformaldehyde solution for 
60mins or immediately frozen in liquid nitrogen. Excised hearts were drained of blood, 
weighed and either flash frozen or immersed in 4% paraformaldehyde for 24 hours. Brain 
and kidney tissue was also flash frozen. All frozen tissues were stored at -80
o
C until 
required.  Lung tissue was excised in to DMEM growth media (Sigma Aldrich) supplemented 
with 10% (v/v) fetal calf serum (Gibco) and 1% (v/v) penicillin-streptomycin. 
Mouse lung endothelial cell (MLEC) isolation 
MLECs were isolated from 6 month old WT and 6 month old PMCA1
Ht
 mice as previously 
described (Oblander et al. 2005; Baggott et al. 2014).  
Western blot analysis 
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Proteins were extracted, separated and transferred as previously described (Mohamed et al. 
2016). Sufficient protein extract was yielded by extracting from half of the heart, half of one 
kidney and one hemisphere of the brain from individual animals, whilst aortic proteins were 
extracted from aortae pooled from 6-10 animals. Membranes were probed with monoclonal 
antibodies against PMCA1 or GAPDH (Abcam) at 1µg/mL or 0.2µg/mL respectively, 
overnight at 4°C or after 3 hours at room temperature. Hydrogen peroxide conjugated 
secondary antibodies were detected using ECL detection reagents (Amersham). 
Quantitative PCR (qPCR) 
Tissues were homogenised by hand under TRIzol Reagent (Invitrogen) with nucleic acids 
extracted by phenol-chloroform precipitation and eluted in diethylpyrocarbonate (DEPC)-
treated deionized water. Total RNA was extracted from MLEC as previously described 
(Baggott et al. 2014). Total RNA was treated with amplification grade DNAse 1 (Sigma-
Aldrich) and quantified using a NanoDrop spectrophotometer (Thermo Scientific). 
Complimentary DNA (cDNA) was generated using a High Capacity cDNA Reverse 
Transcription Kit with RNase inhibitors (Multiscribe Reverse Transcriptase. Applied 
Biosystems) following the manufacturer’s protocol. The mRNA level of genes of interest in 
the sample was determined in triplicate following a real-time PCR reaction on a 7500 Fast 
Real Time PCR machine for a 10µL reaction using TaqMan® gene expression assays (20X 
primers and probe) and Gene Expression Master Mix (2X TaqMan® Universal mix) (all 
Applied Biosystems). Gene expression was normalized for control gene expression (GAPDH) 
and calculated according to the ΔΔCT method (Livak & Schmittgen 2001). 
Immunohistochemistry 
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Fixed aortic tissue was embedded in paraffin and sectioned at 5µm thickness (Leica 2255 
microtome). A polyclonal antibody to PMCA1 (Sigma-Aldrich. 1:50 in 5% horse serum, 16 
hours, 4°C) was detected with an anti-rabbit horseradish peroxidise conjugated secondary 
antibody (ThermoFisher. 1:200) and colour visualisation was obtained by incubating sections 
in prepared DAB reagent (Dako) for 15 minutes, with subsequent staining in haematoxylin 
solution for 20 seconds to stain nuclei. 
Pressure myography 
Mesenteric arteries were cleared of adherent tissue and fat and 3
rd
 order arteries isolated 
and mounted on a pressure myograph (Living Systems Instrumentation, USA), pressurised to 
an intravascular pressure of 60mmHg and superfused with physiological salt solution (PSS) 
of composition (in mM) 119 NaCl, 4.7 KCl, 2.4 MgSO4, 25 NaHCO3, 1.18 KH2PO4, 0.07 
K2EDTA, 6.05 glucose, 1.6 CaCl2, aerated with 5% CO2/95% air mix and heated to 37°C.  
Intraluminal diameter (L) and wall thicknesses (W) were continuously measured by video 
dimension analyser (Hausman et al. 2012). Arterial contraction in response to 100mM 
potassium solution (high K
+
: K
+
 osmotically replacing Na
+
 in physiological buffer), and 
subsequent dilation in physiological buffer were recorded. Arteries were superfused with 
increasing concentration of noradrenaline (NA) and a dose-response curve to the stimulus 
constructed. Arterial passive properties were measured following superfusion with 
nominally calcium-free buffer for 30 minutes at intravascular pressures of 5 to 140 mmHg 
(5, 10, 20mmHg and subsequently increasing in 20mmHg steps). Wall thickness to lumen 
diameter ratio (W:L), cross sectional area (CSA), stress, strain and incremental elastic 
modulus (β) were derived from the recorded diameter and wall thicknesses, as described 
previously (Hausman et al. 2012). 
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For simultaneous measurement of intracellular free calcium ([Ca
2+
]i) and arterial 
contractility, isolated segments of mesenteric arteries were incubated with 20µM Indo-1-
AM (Cell Signalling) in HEPES-buffered physiological solution for 90 minutes at room 
temperature and then 30 minutes at 37°C before being mounted and superfused as 
described above. The pressure myograph bath was placed atop an inverted microscope, 
excited at 340nm and emissions measured via photomultipliers at 400nm and 500nm as 
previously described. Following correction for auto fluorescence the 400:500nm emission 
ratio (F400/F500) was determined. Due to problems associated with calibrating INDO-1 in 
intact tissues this ratio was used as an indication of [Ca
2+
]i. Previous work has shown that 
there is a good agreement between changes in the INDO-1 400:500nm emission ratio and 
changes in [Ca
2+
]i in vascular smooth muscle (Austin and Wray, 1995). Basal F400/F500 levels 
were compared between groups. 
To specifically assess arterial tone, vessels were mounted as described above and 
superfused in heated PSS for 45 minutes. Intraluminal pressure was then reduced to 
5mmHg and vessels allowed to equilibrate for 5-10mins as arterial diameter stabilised. 
Pressure was subsequently increased incrementally to 10, 20, 40, 60, 80 and 100mmHg (Ca
2+
 
containing conditions). Intraluminal pressure was then set to 60mmHg and arteries were 
superfused with nominally Ca
2+
-free buffer for 30 minutes before pressure was reduced to 
5mmHg and subsequently sequentially increased as previously described (nominally Ca
2+
 
free conditions). 
Statistical Analysis 
Contractile responses are expressed as a percentage contraction to the stimulus relative to 
the resting lumen diameter in buffer solution. Contraction to NA is plotted as a cumulative 
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dose-response to log[NA]. The log[NA] value for 50% contraction (logEC50) was calculated 
for each artery, and for each genotype group the mean ± SEM is reported. Intrinsic 
myogenic tone at each pressure step was derived from the difference in lumen diameter (D) 
between passive (nominally Ca
2+
 free) and active (Ca
2+
 containing solution) conditions and 
expressed relative to the passive condition ((Dpassive – Dactive)/Dpassive).  This ratio is presented 
as a % value of the respective passive condition at the defined internal pressure. The 
differences between means was considered significant at p <0.05 (*). Data was analysed 
using Graph Pad Prism 5 software. T-Test or 2-way ANOVA, with Bonferroni post hoc test, 
were applied as appropriate. Data plotted as mean ± SEM; n=number of animals.  
Acknowledgments 
This work was supported by a programme grant from the Medical Research Council UK. S. K. 
Hammad received financial support from the University of Zagazig and A. Njegic from British 
Heart Foundation as a PhD candidate during this project. 
Disclosures 
The authors declare no conflict of interest. 
Author Contributions 
R. Little, M. Zi, S. Hammad, L. Nguyen, A. Njegic, S. Kurusamy, A. Armesilla, S. Prehar 
performed the research 
R. Little, M. Zi, S. Hammad, A. Njegic analysed the data 
C Austin, EJ Cartwright and L Neyses designed the research study 
L Neyses, EJ Cartwright and C Austin contributed to acquiring funding 
R Little, C Austin, and EJ Cartwright contributed to writing the manuscript 
 
Page 21 of 35
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support: (434) 964 4100
Aging Cell
For Peer Review
21 
 
REFERENCES 
Austin C ,  Wray S (1995). The effects of extracellular pH and calcium change on force and 
intracellular calcium in rat vascular smooth muscle. J Physiol. 488 ( Pt 2), 281-291. 
Baggott RR, Alfranca A, Lopez-Maderuelo D, Mohamed TM, Escolano A, Oller J, Ornes BC, Kurusamy 
S, Rowther FB, Brown JE, Oceandy D, Cartwright EJ, Wang W, Gomez-del Arco P, Martinez-
Martinez S, Neyses L, Redondo JM ,  Armesilla AL (2014). Plasma membrane calcium ATPase 
isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through 
interaction with calcineurin. Arteriosclerosis, thrombosis, and vascular biology. 34, 2310-
2320. 
Bakker EN, van der Meulen ET, van den Berg BM, Everts V, Spaan JA ,  VanBavel E (2002). Inward 
remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res. 39, 
12-20. 
Buford TW (2016). Hypertension and aging. Ageing Res Rev. 26, 96-111. 
Buus NH, Mathiassen ON, Fenger-Gron M, Praestholm MN, Sihm I, Thybo NK, Schroeder AP, 
Thygesen K, Aalkjaer C, Pedersen OL, Mulvany MJ ,  Christensen KL (2013). Small artery 
structure during antihypertensive therapy is an independent predictor of cardiovascular 
events in essential hypertension. J Hypertens. 31, 791-797. 
Cartwright EJ, Oceandy D, Austin C ,  Neyses L (2011). Ca2+ signalling in cardiovascular disease: the 
role of the plasma membrane calcium pumps. Sci China Life Sci. 54, 691-698. 
Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, Park M, Cha SH, Kim JW, Han 
BG, Min H, Ahn Y, Park MS, Han HR, Jang HY, Cho EY, Lee JE, Cho NH, Shin C, Park T, Park JW, 
Lee JK, Cardon L, Clarke G, McCarthy MI, Lee JY, Oh B ,  Kim HL (2009). A large-scale genome-
wide association study of Asian populations uncovers genetic factors influencing eight 
quantitative traits. Nat Genet. 41, 527-534. 
Eftekhari A, Rahman A, Schaebel LH, Chen H, Rasmussen CV, Aalkjaer C, Buus CL ,  Mulvany MJ 
(2007). Chronic cystamine treatment inhibits small artery remodelling in rats. J Vasc Res. 44, 
471-482. 
Feng M, Whitesall S, Zhang Y, Beibel M, D'Alecy L ,  DiPetrillo K (2008). Validation of volume-pressure 
recording tail-cuff blood pressure measurements. Am J Hypertens. 21, 1288-1291. 
Folkow B (1982). Physiological aspects of primary hypertension. Physiol Rev. 62, 347-504. 
Fujiwara A, Hirawa N, Fujita M, Kobayashi Y, Okuyama Y, Yatsu K, Katsumata M, Yamamoto Y, 
Ichihara N, Saka S, Toya Y, Yasuda G, Goshima Y, Tabara Y, Miki T, Ueshima H, Ishikawa Y ,  
Umemura S (2014). Impaired nitric oxide production and increased blood pressure in 
systemic heterozygous ATP2B1 null mice. J Hypertens. 32, 1415-1423; discussion 1423. 
Gonzalez JM, Somoza B, Conde MV, Fernandez-Alfonso MS, Gonzalez MC ,  Arribas SM (2008). 
Hypertension increases middle cerebral artery resting tone in spontaneously hypertensive 
rats: role of tonic vasoactive factor availability. Clin Sci (Lond). 114, 651-659. 
Harvey A, Montezano AC ,  Touyz RM (2015). Vascular biology of ageing-Implications in 
hypertension. J Mol Cell Cardiol. 83, 112-121. 
Hausman N, Martin J, Taggart MJ ,  Austin C (2012). Age-related changes in the contractile and 
passive arterial properties of murine mesenteric small arteries are altered by caveolin-1 
knockout. J Cell Mol Med. 16, 1720-1730. 
Heagerty AM, Heerkens EH ,  Izzard AS (2010). Small artery structure and function in hypertension. J 
Cell Mol Med. 14, 1037-1043. 
Intengan HD ,  Schiffrin EL (2001). Vascular remodeling in hypertension: roles of apoptosis, 
inflammation, and fibrosis. Hypertension. 38, 581-587. 
Izzard AS, Bund SJ ,  Heagerty AM (1996). Myogenic tone in mesenteric arteries from spontaneously 
hypertensive rats. Am J Physiol. 270, H1-6. 
Page 22 of 35
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support: (434) 964 4100
Aging Cell
For Peer Review
22 
 
Izzard AS, Horton S, Heerkens EH, Shaw L ,  Heagerty AM (2006). Middle cerebral artery structure 
and distensibility during developing and established phases of hypertension in the 
spontaneously hypertensive rat. J Hypertens. 24, 875-880. 
Kang LS, Kim S, Dominguez JM, 2nd, Sindler AL, Dick GM ,  Muller-Delp JM (2009). Aging and muscle 
fiber type alter K+ channel contributions to the myogenic response in skeletal muscle 
arterioles. J Appl Physiol (1985). 107, 389-398. 
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK ,  He J (2005). Global burden of 
hypertension: analysis of worldwide data. Lancet. 365, 217-223. 
Kobayashi Y, Hirawa N, Tabara Y, Muraoka H, Fujita M, Miyazaki N, Fujiwara A, Ichikawa Y, 
Yamamoto Y, Ichihara N, Saka S, Wakui H, Yoshida S, Yatsu K, Toya Y, Yasuda G, Kohara K, 
Kita Y, Takei K, Goshima Y, Ishikawa Y, Ueshima H, Miki T ,  Umemura S (2012). Mice lacking 
hypertension candidate gene ATP2B1 in vascular smooth muscle cells show significant blood 
pressure elevation. Hypertension. 59, 854-860. 
Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL, Morrison AC, Johnson AD, 
Aspelund T, Aulchenko Y, Lumley T, Kottgen A, Vasan RS, Rivadeneira F, Eiriksdottir G, Guo X, 
Arking DE, Mitchell GF, Mattace-Raso FU, Smith AV, Taylor K, Scharpf RB, Hwang SJ, 
Sijbrands EJ, Bis J, Harris TB, Ganesh SK, O'Donnell CJ, Hofman A, Rotter JI, Coresh J, 
Benjamin EJ, Uitterlinden AG, Heiss G, Fox CS, Witteman JC, Boerwinkle E, Wang TJ, 
Gudnason V, Larson MG, Chakravarti A, Psaty BM ,  van Duijn CM (2009). Genome-wide 
association study of blood pressure and hypertension. Nat Genet. 41, 677-687. 
Lewington S, Clarke R, Qizilbash N, Peto R ,  Collins R (2002). Age-specific relevance of usual blood 
pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 
prospective studies. Lancet. 360, 1903-1913. 
Little R, Cartwright EJ, Neyses L ,  Austin C (2016). Plasma membrane calcium ATPases (PMCAs) as 
potential targets for the treatment of essential hypertension. Pharmacol Ther. 159, 23-34. 
Livak KJ ,  Schmittgen TD (2001). Analysis of relative gene expression data using real-time 
quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25, 402-408. 
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer 
G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, 
Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber 
B ,  Zannad F (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: 
the Task Force for the management of arterial hypertension of the European Society of 
Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 31, 1281-
1357. 
Martinez-Lemus LA, Hill MA, Bolz SS, Pohl U ,  Meininger GA (2004). Acute mechanoadaptation of 
vascular smooth muscle cells in response to continuous arteriolar vasoconstriction: 
implications for functional remodeling. FASEB J. 18, 708-710. 
Mathiassen ON, Buus NH, Larsen ML, Mulvany MJ ,  Christensen KL (2007a). Small artery structure 
adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J 
Hypertens. 25, 1027-1034. 
Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, Thygesen K, Aalkjaer C, 
Lederballe O, Mulvany MJ ,  Christensen KL (2007b). Small artery structure is an independent 
predictor of cardiovascular events in essential hypertension. J Hypertens. 25, 1021-1026. 
Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS ,  Levy D (2004). Changes 
in arterial stiffness and wave reflection with advancing age in healthy men and women: the 
Framingham Heart Study. Hypertension. 43, 1239-1245. 
Mohamed TM, Abou-Leisa R, Stafford N, Maqsood A, Zi M, Prehar S, Baudoin-Stanley F, Wang X, 
Neyses L, Cartwright EJ ,  Oceandy D (2016). The plasma membrane calcium ATPase 4 
signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy. Nat Commun. 7, 
11074. 
Page 23 of 35
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support: (434) 964 4100
Aging Cell
For Peer Review
23 
 
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres 
JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, 
Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, 3rd, Moy CS, 
Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves 
MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, 
Yeh RW ,  Turner MB (2016). Heart Disease and Stroke Statistics-2016 Update: A Report 
From the American Heart Association. Circulation. 133, e38-e360. 
Mulvany MJ (2012). Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol. 110, 49-
55. 
Mulvany MJ ,  Aalkjaer C (1990). Structure and function of small arteries. Physiol Rev. 70, 921-961. 
Oblander SA, Zhou Z, Galvez BG, Starcher B, Shannon JM, Durbeej M, Arroyo AG, Tryggvason K ,  
Apte SS (2005). Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-
MMP or MMP-14) in lung and submandibular gland development are independent of its role 
in pro-MMP-2 activation. Developmental biology. 277, 255-269. 
Okunade GW, Miller ML, Pyne GJ, Sutliff RL, O'Connor KT, Neumann JC, Andringa A, Miller DA, 
Prasad V, Doetschman T, Paul RJ ,  Shull GE (2004). Targeted ablation of plasma membrane 
Ca2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a 
critical role in hyperactivated sperm motility and male fertility for PMCA4. J Biol Chem. 279, 
33742-33750. 
Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M ,  Agabiti-
Rosei E (2003). Prognostic significance of small-artery structure in hypertension. Circulation. 
108, 2230-2235. 
Shin YB, Lim JE, Ji SM, Lee HJ, Park SY, Hong KW, Lim M, McCarthy MI, Lee YH ,  Oh B (2013). 
Silencing of Atp2b1 increases blood pressure through vasoconstriction. J Hypertens. 31, 
1575-1583. 
Strehler EE, Filoteo AG, Penniston JT ,  Caride AJ (2007). Plasma-membrane Ca(2+) pumps: structural 
diversity as the basis for functional versatility. Biochem Soc Trans. 35, 919-922. 
Szewczyk MM, Davis KA, Samson SE, Simpson F, Rangachari PK ,  Grover AK (2007). Ca2+-pumps and 
Na2+-Ca2+-exchangers in coronary artery endothelium versus smooth muscle. J Cell Mol 
Med. 11, 129-138. 
Tabara Y, Kohara K, Kita Y, Hirawa N, Katsuya T, Ohkubo T, Hiura Y, Tajima A, Morisaki T, Miyata T, 
Nakayama T, Takashima N, Nakura J, Kawamoto R, Takahashi N, Hata A, Soma M, Imai Y, 
Kokubo Y, Okamura T, Tomoike H, Iwai N, Ogihara T, Inoue I, Tokunaga K, Johnson T, 
Caulfield M, Munroe P, Umemura S, Ueshima H ,  Miki T (2010). Common variants in the 
ATP2B1 gene are associated with susceptibility to hypertension: the Japanese Millennium 
Genome Project. Hypertension. 56, 973-980. 
Tabara Y, Kohara K ,  Miki T (2012). Hunting for genes for hypertension: the Millennium Genome 
Project for Hypertension. Hypertens Res. 35, 567-573. 
Vessieres E, Dib A, Bourreau J, Lelievre E, Custaud MA, Lelievre-Pegorier M, Loufrani L, Henrion D ,  
Fassot C (2016). Long Lasting Microvascular Tone Alteration in Rat Offspring Exposed In 
Utero to Maternal Hyperglycaemia. PLoS One. 11, e0146830. 
Zacchigna L, Vecchione C, Notte A, Cordenonsi M, Dupont S, Maretto S, Cifelli G, Ferrari A, Maffei A, 
Fabbro C, Braghetta P, Marino G, Selvetella G, Aretini A, Colonnese C, Bettarini U, Russo G, 
Soligo S, Adorno M, Bonaldo P, Volpin D, Piccolo S, Lembo G ,  Bressan GM (2006). Emilin1 
links TGF-beta maturation to blood pressure homeostasis. Cell. 124, 929-942. 
 
 Supporting Information provided: 
Supplementary methods and 2 supporting figures 
Page 24 of 35
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support: (434) 964 4100
Aging Cell
For Peer Review
24 
 
Figure legends 
Figure 1: PMCA1
Ht 
mice display reduced PMCA1 expression  
 
A. Protein expression of PMCA1 was reduced in tissues from 6 month PMCA1
Ht 
mice. Ai. 
Western blots (PMCA1 at 143KDa and GAPDH at 50KDa) and Aii. quantification of PMCA1 
normalised to GAPDH in WT and Ht mice. n=3 & 3. (T-test for each tissue). B. Aortic mRNA 
expression of Atp2b1, presented relative to young WT, was significantly reduced in 6 month 
(n= 8 & 7) and in 18 month old (n=4 & 6) PMCA1
Ht
 mice (P<0.0001). No significant effect of 
age or interaction was determined (P=0.050 and P=0.925 respectively, 2-way ANOVA). C. 
Aortic mRNA expression of Atp2b4, presented relative to young WT, was not significantly 
reduced in 6 month (n= 8 & 7) or in 18 month old (n=4 & 6) PMCA1
Ht
 mice (P=0.714), though 
a significant effect of age was determined (P=0.0003, 2-way ANOVA). D. Detection of 
primary antibody against PMCA1 in aorta from 6 month old WT (Di.) and PMCA1
Ht
 (Dii.) 
mice. Diii. Staining of aorta when primary antibody omitted. Div. Staining of aorta with DAB 
reagent only. Scale bar represents 100µm. E. mRNA expression of Atp2b1 was significantly 
reduced in endothelial cells isolated from lungs of 6 month old PMCA1
Ht
 mice compared to 
cells from age-matched WT mice (n= 3 & 5). F-H. Total kidney mRNA expression of Atp2b4 
(E.), NCX1 (F.) and TRPV5 (G.) was not significantly different in 18 month old PMCA1
Ht
 mice 
versus age matched WT animals. All data plotted as mean ± SEM. *P<0.05, **P<0.01, 
***P<0.001. 
 
 
Figure 2: Conscious BP increases with age in PMCA1
Ht
 mice 
A.  Conscious peripheral BP (Systolic, Ai. and diastolic, Aii.) of PMCA1
Ht
 mice is significantly 
higher at 12 months and then at all older ages (t-test versus age matched WT, n=5-7). B. No 
significant difference in conscious pulse rate is recorded in young or aged PMCA1
Ht
 mice 
(P=0.290, and P=0.972 for interaction. 2-way ANOVA) n=5, 5, 7 & 6. C. Arterial BP (Systolic, 
Ci. and diastolic, Cii.) of 6 month old animals, under anaesthesia, does not significantly differ 
between WT and PMCA1
Ht
 mice (t-test, n=10 & 12). Mean value ± SEM. **P<0.01, 
***P<0.001.   
 
Figure 3: Remodeling of small mesenteric arteries occurs with age in PMCA1
Ht 
mice and 
before a detectable increase in BP. 
A. The internal lumen diameter does not significantly differ between passive mesenteric 
arteries from WT and PMCA1
Ht
 mice at 6 months of age but is significantly smaller in 
PMCA1
Ht
 mice at 9 and 18 months (B & C.). D. Wall thickness is similar at 6 months of age 
and significantly increases with age in PMCA1
Ht
 arteries (E & F.). G, H. & I. The vessel wall 
thickness to lumen ratio (W:L) is significantly increased in arteries from PMCA1
Ht
 mice aged 
6, 9 and 18 months old. J, K & L. The cross sectional area (CSA) of the vessel wall is not 
significantly different between arteries taken from WT and PMCA1
Ht
 mice at any age tested. 
Extra sum of squares F-Test analysis performed. All data plotted as mean value ± SEM. n=4-8 
*P<0.05, **P<0.01, ***P<0.001.   
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Figure 4: Stiffness of resistance arteries increases with age but is not significantly altered in 
arteries from PMCA1
Ht
 mice. 
A. Stress-strain relationship derived from passive properties shows leftward shift for arteries 
from 6 month old mice to 18 month olds. B. The distensibility of arteries from PMCA1
Ht 
mice 
is not significantly different (P=0.215) from arteries of WT mice as shown by incremental 
elastic modulus. A significant increase in age was detected (P=0.022) between arteries from 
6 and 18 month old animals. No significant interaction was determined (0.326) when 
analysing these 2 ages. 2-way ANOVA with Bonferroni post hoc test. Mean ± SEM. n=5-8. 
*P<0.05 
 
Figure 5: Arteries from PMCA1
Ht
 mice contract similarly but display elevated myogenic tone 
and basal intracellular calcium.  
A & B. The magnitude of contraction to a depolarising stimulus (100mM K
+
) is not 
significantly different for arteries from PMCA1
Ht
 mice for both young (A. P=0.773. n=6 & 7) 
and aged (B. P=0.334. n=7 & 6) animals (T-test). C & D. Arteries from PMCA1
Ht
 mice do not 
display a significant difference in contractility to noradrenaline (NA) from both young (C. 
P=0.537. n=6 & 6) and aged (D. P=0.162. n=4 & 6) animals (Non-linear regression 
comparison of fits). E. & F. Arteries from PMCA1
Ht 
mice display significantly elevated 
myogenic tone in both young (E. n=5 & 5) and aged (F. n= 6 & 6) animals (comparison of fit 
analysis). G. & H. A significantly elevated arterial Indo-1 F400/F500 emission ratio, indicative of 
intracellular free Ca
2+
 concentration, was detected at both ages (G. & H, young and old 
respectively. n= 5 & 7 and 7 & 5). All data plotted as mean value ± SEM. **P<0.01. 
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Figure 3: 
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Figure 4: 
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Figure 5: 
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SUPPLEMENTARY MATERIAL 
Genotyping 
Ear tissue was digested in a lysis buffer of composition 50mM Tris, 100mM 
ethylenediaminetetraacetic acid (EDTA) and 0.5% sodium dodecyl sulphate (SDS) with 
50µg/mL proteinase K overnight at 56°C. Isolated DNA was precipitated with isopropanol 
and resuspended in TE buffer (10mM Tris pH 7.5, 1mM EDTA pH 8). Regions surrounding the 
LoxP sites were amplified using primers (Sigma Genosys) of the following sequences,  
Forward: 5’-AGGTGGCTTTAAGACCAGAAACAGGACAGG-3’ 
Reverse: 5’-CTGTGGAGTACATGCTTCGTTCTGC-3’ 
at a final concentration of 0.3pM using ReddyMix Extensor PCR master mix (Thermo 
Scientific AB-0794) in the presence of 0.83mM MgAc. The PCR conditions were 7 minutes 
94°C, followed by 30 cycles of 30 seconds 94°C, 30 seconds 65°C, 5 minutes 68°C with final 
elongation for 10 minutes at 72°C before being held at 4°C. The resulting PCR products were 
separated on a 0.6% agarose gel containing ethidium bromide and visualised by 
transillumination (Bio Rad Chemi Doc). The wild type (WT) amplicon was expected at 6662 
base pairs (bp) with the homozygous amplicon expected at 4703 bp. No homozygous 
amplicon was detected alone as the homozygous knock-out is embryonic lethal (Okunade et 
al. 2004). Obtaining two bands, for both the WT and knock-out amplicon, indicated a 
PMCA1 heterozygous genotype. 
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ADDITIONAL FIGURES 
Figure S1: 
 
 
Figure S1: Aged PMCA1
Ht
 mice with elevated blood pressure do not display an adverse 
cardiac phenotype. A. Fractional shortening, B. stroke volume, and left ventricular (LV) 
posterior wall thickness in C. systole and D. diastole of hearts from 18 month old WT and 
PMCA1
Ht
 mice is not significantly different (n=8 and 9. T-Test). E. Heart weight relative to 
tibia length (HW/TL) is similar for PMCA1
Ht
 mice compared WT at 18 months old (P=0.718, 
T-test. n=8 & 9). F. Cardiomyocyte cell area is similar for PMCA1
Ht
 mice compared WT at 18 
months old (P=0.527, n=4 & 4. T-test). Representative images of haematoxylin and eosin (H 
& E) stained heart sections used in this calculation shown; scale bar represents 50µm. All 
data plotted as mean value ± SEM. 
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Figure S2: 
 
Figure S2: Pressure-lumen diameter relationships significantly differ between active and 
passive conditions for arteries from WT and PMCA1
Ht 
mice.                                                                
A & B. The pressure-diameter relationship in active and passive conditions is significantly 
different for mesenteric arteries from 6 month old WT (A. n=5) and Ht (B. n=5) mice. C & D. 
The pressure-diameter relationship in active and passive conditions is significantly different 
for mesenteric arteries from 18 month old WT (C. n=6) and Ht (D. n=6) mice. Non linear 
regression extra sum of squares F-Test analysis performed. All data plotted as mean value ± 
SEM. *P<0.05, **P<0.01. 
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